000 | 01985 a2200505 4500 | ||
---|---|---|---|
005 | 20250515202215.0 | ||
264 | 0 | _c20100317 | |
008 | 201003s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0008420 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKodiha, Mohamed | |
245 | 0 | 0 |
_aDissecting the signaling events that impact classical nuclear import and target nuclear transport factors. _h[electronic resource] |
260 |
_bPloS one _cDec 2009 |
||
300 |
_ae8420 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aActive Transport, Cell Nucleus _xdrug effects |
650 | 0 | 4 |
_aCell Compartmentation _xdrug effects |
650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
650 | 0 | 4 |
_aCellular Apoptosis Susceptibility Protein _xmetabolism |
650 | 0 | 4 | _aGenes, Reporter |
650 | 0 | 4 | _aHeLa Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aNuclear Envelope _xmetabolism |
650 | 0 | 4 |
_aNuclear Localization Signals _xmetabolism |
650 | 0 | 4 |
_aNuclear Pore Complex Proteins _xmetabolism |
650 | 0 | 4 |
_aNuclear Proteins _xmetabolism |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aSolubility _xdrug effects |
650 | 0 | 4 |
_aStress, Physiological _xdrug effects |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
650 | 0 | 4 |
_aalpha Karyopherins _xmetabolism |
700 | 1 | _aTran, Dan | |
700 | 1 | _aMorogan, Andreea | |
700 | 1 | _aQian, Cynthia | |
700 | 1 | _aStochaj, Ursula | |
773 | 0 |
_tPloS one _gvol. 4 _gno. 12 _gp. e8420 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0008420 _zAvailable from publisher's website |
999 |
_c19420939 _d19420939 |